X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (32) 32
humans (25) 25
psychiatry (22) 22
adult (19) 19
female (18) 18
male (16) 16
middle aged (12) 12
neurosciences (9) 9
pharmacology & pharmacy (9) 9
schizophrenia (8) 8
schizophrenia - drug therapy (8) 8
analysis of variance (7) 7
antipsychotic agents - adverse effects (7) 7
antidepressants (6) 6
dose-response relationship, drug (5) 5
schizophrenia - blood (5) 5
serotonin reuptake inhibitors (5) 5
time factors (5) 5
clozapine - adverse effects (4) 4
clozapine - therapeutic use (4) 4
glucose (4) 4
medical research (4) 4
medicine, experimental (4) 4
obesity (4) 4
obsessive-compulsive disorder (4) 4
prospective studies (4) 4
psychosis (4) 4
psychotropic drugs (4) 4
stress (4) 4
animals (3) 3
antipsychotic agents - administration & dosage (3) 3
antipsychotic agents - therapeutic use (3) 3
antipsychotics (3) 3
benzodiazepines - adverse effects (3) 3
bipolar disorder (3) 3
body mass index (3) 3
brain (3) 3
bulimia nervosa (3) 3
clinical neurology (3) 3
clozapine (3) 3
depression (3) 3
eating disorders (3) 3
food-intake (3) 3
management (3) 3
mood stabilizers (3) 3
pharmacovigilance (3) 3
psychology (3) 3
rats (3) 3
retrospective studies (3) 3
risk (3) 3
risk factors (3) 3
scale (3) 3
treatment outcome (3) 3
young adult (3) 3
1517 (2) 2
adverse drug reactions (2) 2
aged (2) 2
anorexia-nervosa (2) 2
aripiprazole (2) 2
article (2) 2
behavior (2) 2
benzodiazepines (2) 2
biological psychiatry (2) 2
brain - metabolism (2) 2
bulimia (2) 2
bulimia - blood (2) 2
bulimia - epidemiology (2) 2
bulimia - metabolism (2) 2
care and treatment (2) 2
clozapine - administration & dosage (2) 2
clozapine - metabolism (2) 2
comorbidity (2) 2
cortex (2) 2
cortisol (2) 2
depression, mental (2) 2
diabetes-mellitus (2) 2
diagnostic and statistical manual of mental disorders (2) 2
disorder (2) 2
drug interactions (2) 2
drug resistance (2) 2
endocrinology & metabolism (2) 2
europe (2) 2
expression (2) 2
failure (2) 2
feeding behavior - physiology (2) 2
findings that shed new light on the possible pathogenesis of a disease or an adverse effect (2) 2
follow-up studies (2) 2
ghrelin (2) 2
immunity (2) 2
insulin (2) 2
insulin resistance (2) 2
interleukin-6 - blood (2) 2
leptin (2) 2
leptin - blood (2) 2
nerve growth factor receptor (2) 2
nerve growth factors - genetics (2) 2
nerve growth factors - metabolism (2) 2
ocd (2) 2
pharmacokinetics (2) 2
psychiatric status rating scales (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Social Psychiatry, ISSN 0020-7640, 11/2018, Volume 64, Issue 7, pp. 617 - 621
Journal Article
International Clinical Psychopharmacology, ISSN 0268-1315, 07/2019, Volume 34, Issue 4, pp. 206 - 210
Journal Article
Journal of Affective Disorders, ISSN 0165-0327, 02/2019, Volume 245, pp. 174 - 179
Journal Article
Clinical schizophrenia & related psychoses, ISSN 1935-1232, 2019, Volume 12, Issue 4, p. 185
Clozapine-related pericarditis is a rare side effect of the drug. We reported the clinical cases of two women, aged 22 and 28 years, affected by schizophrenia... 
Journal Article
Progress in Neuropsychopharmacology & Biological Psychiatry, ISSN 0278-5846, 2010, Volume 34, Issue 2, pp. 323 - 330
Journal Article
BMJ Case Reports, ISSN 1757-790X, 06/2015, Volume 2015, Issue jun01 1, pp. bcr2014209148 - bcr2014209148
Journal Article
BMJ Case Reports, ISSN 1757-790X, 10/2014, Volume 2014, Issue oct21 1, pp. bcr2014205805 - bcr2014205805
Anecdotal evidence tends to favour olanzapine in the treatment of hallucinations in patients with schizophrenia spectrum disorders; however, no conclusive... 
Recurrence | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Hallucinations - chemically induced | Male | Benzodiazepines - adverse effects | Psychotic Disorders - drug therapy | Psychotropic drugs | Psychosis | Acids | Hallucinations | Schizophrenia | Metabolism | Drug dosages | Smoking | Index Medicus
Journal Article
European Psychiatry, ISSN 0924-9338, 10/2018, Volume 54, pp. 35 - 40
The decision to adopt forced medication in psychiatric care is particularly relevant from a clinical and ethical viewpoint. The European Commission has funded... 
Forced medication | Procedures | Coercive measures | Recommendation | EMERGENCY | RISK-FACTORS | MANAGEMENT | COUNTRIES | PSYCHIATRY | SECLUSION | ADMISSION | RESTRAINT | INPATIENT CARE | ASSOCIATION | Index Medicus
Journal Article